Cargando…

Metformin Protects Cardiomyocyte from Doxorubicin Induced Cytotoxicity through an AMP-Activated Protein Kinase Dependent Signaling Pathway: An In Vitro Study

Doxorubicin (Dox) is one of the most widely used antitumor drugs, but its cumulative cardiotoxicity have been major concerns in cancer therapeutic practice for decades. Recent studies established that metformin (Met), an oral anti-diabetic drug, provides protective effects in Dox-induced cardiotoxic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kobashigawa, Laura C., Xu, Yan Chun, Padbury, James F., Tseng, Yi-Tang, Yano, Naohiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4134245/ https://www.ncbi.nlm.nih.gov/pubmed/25127116 http://dx.doi.org/10.1371/journal.pone.0104888

Ejemplares similares

In vitro silencing of the insulin receptor attenuates cellular accumulation of fibronectin in renal mesangial cells
por: Yano, Naohiro, et al.
Publicado: (2012)

Protective effect of guggulsterone against cardiomyocyte injury induced by doxorubicin in vitro
por: Wang, Wen-Ching, et al.
Publicado: (2012)

Cardioprotective effect of metformin against doxorubicin cardiotoxicity in rats
por: Tseng, Yi-Tang
Publicado: (2016)

AMP kinase activation and glut4 translocation in isolated cardiomyocytes
por: Webster, Ingrid, et al.
Publicado: (2010)

Liquiritin Attenuates Lipopolysaccharides-Induced Cardiomyocyte Injury via an AMP-Activated Protein Kinase-Dependent Signaling Pathway
por: Mou, Shan-Qi, et al.
Publicado: (2021)

LOW GLUCOSE ENHANCES THE CYTOPROTECTIVE EFFECT OF METFORMIN AGAINST DOXORUBICIN-INDUCED CYTOTOXICITY
por: Ameer, Fathima, et al.
Publicado: (2019)

Metformin attenuates motility, contraction, and fibrogenic response of hepatic stellate cells in vivo and in vitro by activating AMP-activated protein kinase
por: Li, Zhen, et al.
Publicado: (2018)

Effects of metformin on cardiomyocytes
Publicado: (2012)

Metformin suppresses adipogenesis through both AMP-activated protein kinase (AMPK)-dependent and AMPK-independent mechanisms
por: Chen, Suet Ching, et al.
Publicado: (2017)

Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner
por: Rattan, R, et al.
Publicado: (2011)

Activation of AMP-activated protein kinase by metformin protects human coronary artery endothelial cells against diabetic lipoapoptosis
por: Eriksson, Linnéa, et al.
Publicado: (2014)

Metformin improves boar sperm quality via 5′-AMP-activated protein kinase-mediated energy metabolism in vitro
por: Li, Rong-Nan, et al.
Publicado: (2020)

Resveratrol Protects Osteoblasts Against Dexamethasone-Induced Cytotoxicity Through Activation of AMP-Activated Protein Kinase
por: Wang, Liang, et al.
Publicado: (2020)

Metformin Sensitizes Leukemia Cells to Vincristine via Activation of AMP-activated Protein Kinase
por: Yi, Yong, et al.
Publicado: (2017)

Ginsenoside compound-Mc1 attenuates oxidative stress and apoptosis in cardiomyocytes through an AMP-activated protein kinase–dependent mechanism
por: Hong, So-hyeon, et al.
Publicado: (2020)

In Vitro Anti-Echinococcal and Metabolic Effects of Metformin Involve Activation of AMP-Activated Protein Kinase in Larval Stages of Echinococcus granulosus
por: Loos, Julia A., et al.
Publicado: (2015)

Protection against Doxorubicin-Induced Cytotoxicity by Geniposide Involves AMPKα Signaling Pathway
por: Meng, Yan-Yan, et al.
Publicado: (2019)

Curcumin Downregulates Phosphate Carrier and Protects against Doxorubicin Induced Cardiomyocyte Apoptosis
por: Junkun, Lu, et al.
Publicado: (2016)

Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity
por: Guo, Rui, et al.
Publicado: (2018)

Doxorubicin-induced oxidative stress: The protective effect of nicorandil on HL-1 cardiomyocytes
por: Asensio-López, Mari C., et al.
Publicado: (2017)

Decreased AMP‐activated protein kinase (AMPK) function and protective effect of metformin in neonatal rat pups exposed to hyperoxia lung injury
por: Yadav, Abha, et al.
Publicado: (2020)

Metformin Augments Panobinostat's Anti-Bladder Cancer Activity by Activating AMP-Activated Protein Kinase()()
por: Okubo, Kazuki, et al.
Publicado: (2019)

Protective effect of miR378* on doxorubicin‐induced cardiomyocyte injury via calumenin
por: Wang, Yu, et al.
Publicado: (2018)

Correction: Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity
por: Guo, Rui, et al.
Publicado: (2019)

Protective effects of protocatechuic acid against doxorubicin- and arsenic trioxide-induced toxicity in cardiomyocytes
por: Shafiee, Fatemeh, et al.
Publicado: (2023)

Essential Amino Acids-Rich Diet Increases Cardiomyocytes Protection in Doxorubicin-Treated Mice
por: Corsetti, Giovanni, et al.
Publicado: (2023)

Modulation in vitro and in vivo of cytotoxicity but not cellular levels of doxorubicin by the calmodulin inhibitor trifluoperazine is dependent on the level of resistance.
por: Ganapathi, R., et al.
Publicado: (1988)

Metformin protects against PM(2.5)-induced lung injury and cardiac dysfunction independent of AMP-activated protein kinase α2
por: Gao, Junling, et al.
Publicado: (2019)

Targeting metabolism and AMP-activated kinase with metformin to sensitize non-small cell lung cancer (NSCLC) to cytotoxic therapy: translational biology and rationale for current clinical trials
por: Troncone, Michael, et al.
Publicado: (2017)

Dexrazoxane Protects Cardiomyocyte from Doxorubicin-Induced Apoptosis by Modulating miR-17-5p
por: Yu, Xiaoxue, et al.
Publicado: (2020)

Metformin protects against insulin resistance induced by high uric acid in cardiomyocytes via AMPK signalling pathways in vitro and in vivo
por: Jiao, Zhenyu, et al.
Publicado: (2021)

Testosterone Antagonizes Doxorubicin‐Induced Senescence of Cardiomyocytes
por: Altieri, Paola, et al.
Publicado: (2016)

Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status
por: Stephenne, X., et al.
Publicado: (2011)

A possible role for AMP-activated protein kinase activated by metformin and AICAR in human granulosa cells
por: Kai, Yufuko, et al.
Publicado: (2015)

Alteration of Type II Regulatory Subunit of cAMP‐dependent Protein Kinase in Human Cisplatin‐resistant Cells as a Basis of Collateral Sensitivity to 8‐Chloro‐cAMP
por: Nishio, Kazuto, et al.
Publicado: (1992)

Effect of Metformin on Doxorubicin-Induced Memory Dysfunction
por: Alharbi, Ibrahim, et al.
Publicado: (2020)

Imaging alterations of cardiomyocyte cAMP microdomains in disease
por: Froese, Alexander, et al.
Publicado: (2015)

Protective effects of AMP-activated protein kinase in the cardiovascular system
por: Xu, Qiang, et al.
Publicado: (2010)

MiR-21 Protected Cardiomyocytes against Doxorubicin-Induced Apoptosis by Targeting BTG2
por: Tong, Zhongyi, et al.
Publicado: (2015)

Protective Effect of miR-204 on Doxorubicin-Induced Cardiomyocyte Injury via HMGB1
por: Du, Youyou, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sp648t2p68mfdec0bc2vi0njsf